Prolonged exposure and sertraline treatments for posttraumatic stress disorder also improve multiple indicators of social functioning

Journal article

Trauma survivors with posttraumatic stress disorder (PTSD) frequently also suffer from difficulties in social functioning that range across emotional, cognitive, and environmental domains. A detailed evaluation of the differential impacts of effective PTSD treatments on social functioning is needed. Men and women (N = 200) with chronic PTSD received 10 weeks of prolonged exposure (PE) or sertraline in a randomized clinical trial and were followed for 24 months. A secondary data analysis examined changes in social functioning with regard to fear of intimacy; receipt of social support; and distress, avoidance, and negative cognitions in social situations. Effects were examined between treatments over time, controlling for baseline functioning. There were large, durable improvements across all indices. Compared to sertraline, PE was more efficient at reducing fear of intimacy and distress from negative social cognitions by posttreatment, ds = 0.94–1.14. Patients who received sertraline continued to improve over the course of follow‐up, ds = 0.54–1.17. The differential speed of therapeutic effects may argue for more direct mechanisms in cognitive behavioral interventions versus cascade effects in serotonin reuptake inhibitors. Notably, both treatments produced substantial social benefits for trauma survivors with social functioning difficulties, and effect sizes were comparable to typical reductions in PTSD, depression, and anxiety.

Authors: Graham, B; Garcia, NM; Bergman, HE; Feeny, NC; Zoellner, LA

• Publication status: Published
• Peer review status: Peer reviewed
• Publisher: Wiley
• Journal: Journal of Traumatic Stress
• Volume: 33
• Issue: 4
• Pages: 488-499
• Publication date: 2020-07-13
• Acceptance date: 2020-04-29
• DOI: 10.1002/jts.22570
• EISSN: 1573-6598
• ISSN: 0894-9867
• Language: English
• Keywords: FFR